Bluebird Bio Provides Update on Severe Genetic Disease Programs and Business Operations

“We remain committed to our pioneering mission to deliver one-time gene therapies with life-long benefits to our patients,” said Andrew Obenshain, president, severe genetic diseases, bluebird bio.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: